Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Screening for lung cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Abstract:
The American Cancer Society has updated its guideline for lung cancer screening in individuals who are at higher risk due to their smoking history. The guideline recommends yearly screening with a low-dose computed tomography (LDCT) scan for people aged 50-80 who smoke or used to smoke and have a 20 pack-year history of smoking. Before deciding to be screened, individuals should have a discussion with their healthcare provider about the purpose, benefits, limits, and possible harms of screening. It is important to note that people with serious health problems or who are unable or unwilling to receive treatment if lung cancer is found should not be screened. Additionally, individuals who still smoke should be counseled about quitting and provided with resources to help them quit. Lung cancer is one of the most common types of cancer and the leading cause of cancer deaths. Screening can help find early-stage lung cancers when treatment is most likely to be successful. However, it is important to consider the limitations and risks of screening, such as the possibility of false-positive results and the small amount of radiation used in LDCT scans. Ultimately, the decision to undergo screening should be made in consultation with a healthcare provider. [Extracted from the article]
- Abstract:
Copyright of CA: A Cancer Journal for Clinicians is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.